top of page

Anorexia Nervosa: Scientists Find a Genetic Clue Linked to Fat Storage

Oct 26
4 min read

What if part of the biology of anorexia nervosa were linked to a cellular mechanism for fat storage? Scientists have identified potentially harmful genetic variants in the PLIN4 gene. This gene plays a role in the organization of lipid droplets, structures that store fat within cells. The discovery opens a new line of inquiry into the genetics of anorexia nervosa, though it does not yet explain how these alterations might contribute to the development of the disorder.


Anorexia nervosa is a serious eating disorder characterized by an intense fear of gaining weight, persistent food restriction, and a distorted perception of one’s own body. While psychological, social, and environmental factors contribute to the development of the condition, research shows that genetics can also influence an individual's vulnerability.


To investigate this genetic component, scientists analyzed the genetic material of people with anorexia nervosa, searching for rare alterations that might help explain why some individuals develop the disorder. The goal was to identify genes that could be involved in the biological mechanisms underlying the condition.



To do this, the researchers used a technique called whole-exome sequencing, which allows for the reading of the regions of genetic material that contain the instructions for producing proteins.


Proteins perform countless functions within the body, ranging from cell-to-cell communication to energy storage. Rather than analyzing the entire genetic material, the scientists focused their investigation on the regions containing these instructions, looking for small alterations that could change how proteins function.


Initially, they studied families with a high concentration of anorexia nervosa cases, as the presence of multiple affected family members can help identify shared genetic traits. Based on this research, they selected 32 candidate genes for more detailed analysis in 154 individuals with anorexia nervosa who were not related to one another.



In the next step, scientists checked how many of these 154 people had rare and potentially harmful genetic variants in each of the 32 genes. A genetic variant is a difference in the sequence of genetic material. It may not have important consequences, but, in certain situations, it can alter the production or functioning of a protein.


To select the most relevant variants, the researchers considered those found in less than 1% of the population to be rare and used computational tools to estimate the possibility of them impairing protein function. They also identified changes that could stop the production of a protein before it was completed.


They then compared the frequency of these variants with genetic data from a large reference population of European ancestry. This comparison made it possible to verify whether certain changes appeared more frequently among people with anorexia nervosa than would be expected in the general population.



The primary finding involved the PLIN4 gene. Among the 154 participants with anorexia nervosa, 17 approximately 11%, carried rare variants in this gene that were considered potentially harmful. In the reference population, this proportion was approximately 3.2%.


In other words, these variants were found about 3.4 times more frequently among the study participants. The association remained statistically significant even after the researchers applied the necessary correction for the 32 genes investigated.


Furthermore, six participants carried variants that could disrupt the normal production of the protein. In four of these six cases, the researchers identified at least one close relative who also had anorexia nervosa and carried the same genetic variant.


This occurrence, known as co-segregation, provides an additional clue that the variant may be linked to the disease within these families. However, the specific analysis of the variants capable of disrupting protein production did not yield sufficiently strong statistical evidence after accounting for multiple comparisons.



The PLIN4 gene is involved in the formation and organization of lipid droplets, small, fat-storing structures found within cells. These structures serve as more than just energy reserves; they also play a role in organizing and regulating the metabolism of lipids, a category of molecules that includes the fats utilized by the body.


This discovery raises the possibility that alterations in this area of ​​cell biology may contribute to the mechanisms underlying anorexia nervosa. However, the study did not demonstrate how PLIN4 variants might influence eating behavior, body perception, or the development of the disorder.


Furthermore, this does not mean that everyone with these variants will develop anorexia nervosa, nor does it imply that all individuals with anorexia have alterations in this gene. These findings represent an important genetic clue, which will need to be investigated in larger groups and through experiments designed to clarify how such alterations affect the functioning of cells and the body as a whole.



READ MORE:


Increased frequency of rare damaging variants in PLIN4 in patients with anorexia nervosa

Michael Lutter, Lucas G. Casten, Jacob J. Michaelson, Guido K. W. Frank, Alenka Čopič, Michelle S. Mazei-Robison, and Alfred J. Robison

Frontiers in Psychiatry. Volume 17. Oct 1, 2026

DOI: 10.3389/fpsyt.2026.1937613


Abstract: 


Background: Anorexia nervosa (AN) is a severe psychiatric disorder characterized by pathological fear of weight gain, persistent restriction of energy intake, and pervasive body image disturbance. Although AN is substantially heritable, the rare coding variants contributing to susceptibility remain incompletely defined. Pedigree-based whole-exome sequencing studies can help to identify rare, high-effect protein-coding variants and thereby elucidate disease mechanisms.Methods: Whole-exome sequencing was performed on AN-dense family pedigrees to identify candidate genes. The frequency of rare (minor allele frequency <1%), putatively damaging [combined annotation-dependent depletion (CADD) >15, including predicted loss-of-function (LOF)] variants in 32 candidate genes was assessed in 154 unrelated probands of European ancestry. Carrier counts were compared against gnomAD v4 non-Finnish European reference using a TRAPD-style coverage-adjusted denominator (maximum allele number/2 across qualifying sites per gene). Significance was assessed by one-sided Fisher exact test, Bonferroni-corrected across 32 candidate genes.Results: PLIN4 was the only gene enriched in AN cases at Bonferroni-corrected significance: 17 of 154 patients (11.0%) carried a rare damaging variant versus 3.2% in gnomAD non-Finnish Europeans [odds ratio (OR) 3.86, 95% confidence interval (CI) 2.35 to 6.35; one-sided Fisher p = 9.98e−06; Bonferroni-corrected p = 3.19e−04]. The result is preserved with the index proband removed (n = 153; OR 3.64, 95% CI 2.18 to 6.07; corrected p = 1.13e−03). Six of 154 patients carried predicted LOF variants; 4 of 6 had at least one AN-affected first- or second-degree relative carrying the same variant, providing co-segregation evidence. The LOF-only burden did not survive Bonferroni correction in isolation.Conclusions: Patients with AN carry a statistically significant excess of rare, putatively damaging variants in PLIN4, at a threshold surviving Bonferroni correction across 32 candidate genes. These findings implicate lipid-droplet biology as a candidate contributor to AN pathophysiology.

 
 
 

Comments


© 2020-2026 by Lidiane Garcia

bottom of page